Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-346995

Chief Executive Officer sold 51,499 shares at an average $47.25 ($2,433,176)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-08-10 Sale 10b5-1 −14,171 $45.97 $651,492 523,436 D
Ceesay Abraham Chief Executive Officer 2026-08-10 Sale 10b5-1 −8,370 $46.75 $391,280 515,066 D
Ceesay Abraham Chief Executive Officer 2026-08-11 Sale 10b5-1 −3,664 $46.90 $171,837 511,402 D
Ceesay Abraham Chief Executive Officer 2026-08-11 Sale 10b5-1 −19,500 $48.04 $936,846 491,902 D
Ceesay Abraham Chief Executive Officer 2026-08-11 Sale 10b5-1 −5,794 $48.62 $281,721 486,108 D
Open-market sales · 51,499 sh · avg $47.25 · $2,433,176
Loading xslF345X06/ownership.xml…